A detailed history of Point72 Hong Kong LTD transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Point72 Hong Kong LTD holds 11,402 shares of PTCT stock, worth $447,300. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,402
Previous 57,530 80.18%
Holding current value
$447,300
Previous $1.76 Million 75.95%
% of portfolio
0.03%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.39 - $37.66 $1.4 Million - $1.74 Million
-46,128 Reduced 80.18%
11,402 $423,000
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $1.19 Million - $1.94 Million
48,307 Added 523.77%
57,530 $1.76 Million
Q1 2024

May 15, 2024

BUY
$24.15 - $31.95 $222,735 - $294,674
9,223 New
9,223 $268,000
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $179,243 - $230,639
4,283 Added 106.49%
8,305 $417,000
Q2 2022

Aug 15, 2022

BUY
$25.6 - $45.23 $102,963 - $181,915
4,022 New
4,022 $161,000
Q1 2022

May 16, 2022

SELL
$33.33 - $44.6 $93,457 - $125,058
-2,804 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$35.36 - $41.86 $99,149 - $117,375
2,804 New
2,804 $112,000
Q3 2021

Nov 15, 2021

SELL
$37.01 - $44.74 $23,094 - $27,917
-624 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$37.95 - $49.37 $8,197 - $10,663
216 Added 52.94%
624 $26,000
Q1 2021

May 17, 2021

BUY
$46.8 - $68.92 $19,094 - $28,119
408 New
408 $19,000
Q4 2019

Feb 14, 2020

SELL
$32.22 - $50.07 $26,033 - $40,456
-808 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$33.82 - $48.17 $27,326 - $38,921
808 New
808 $27,000
Q4 2018

Feb 14, 2019

SELL
$29.83 - $46.51 $87,222 - $135,995
-2,924 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$33.9 - $47.77 $99,123 - $139,679
2,924 New
2,924 $137,000
Q2 2018

Aug 14, 2018

SELL
$25.7 - $47.88 $32,793 - $61,094
-1,276 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$17.46 - $32.59 $22,278 - $41,584
1,276 New
1,276 $35,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.